• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

生物银行准入治理:以特龙网络遗传生物银行为例。

Governance of Access in Biobanking: The Case of Telethon Network of Genetic Biobanks.

机构信息

CIRSFID ALMA-AI, University of Bologna, Bologna, Italy.

Department of Rare Skeletal Disorders, IRCCS Istituto Ortopedico Rizzoli, Bologna, Italy.

出版信息

Biopreserv Biobank. 2021 Dec;19(6):483-492. doi: 10.1089/bio.2021.0057. Epub 2021 Dec 3.

DOI:10.1089/bio.2021.0057
PMID:34870481
Abstract

The discussion concerning the measure of the quality of a biobank should focus not only on the number of stored samples and their quality but also on the assessment of their access arrangements and governance. This article aims at contributing to the ongoing debate on samples and data access governance in biobanking by presenting the case of the Telethon Network of Genetic Biobanks (TNGB). We attempt to contribute to the need for clear and available access criteria and harmonization in access arrangements to maximize the influence of biobanks in the progress of biomedical research. We reviewed all the sample requests submitted to the TNGB from 2008 to 2020, focusing on those rejected by the Access Committee and the reasons behind the rejections. The analysis of the reasons behind the rejected requests allowed us to analyze how those relate to the issues of scientific misconduct, prioritization, and noncompliance with the biobank's mission. We discuss those issues in light of the actions and motivations used by TNGB in the access decision-making process. Based on this analysis, we suggest that a cross-implementation of a checklist for access assessment would improve the whole access process, ensuring a more transparent and smoother governance. Finally, we conclude that the TNGB's Charter and approach toward access governance could contribute as an important reference point to deal with the issues that have emerged in the international discussion on the topic.

摘要

关于生物库质量的衡量标准,不仅应关注存储样本的数量及其质量,还应评估其获取安排和治理情况。本文旨在通过介绍 Telethon 遗传生物库网络 (TNGB) 的案例,为生物库中样本和数据获取治理的持续辩论做出贡献。我们试图为明确和可用的获取标准以及获取安排的协调做出贡献,以最大限度地发挥生物库在推进生物医学研究方面的作用。我们审查了 2008 年至 2020 年提交给 TNGB 的所有样本请求,重点关注被获取委员会拒绝的请求以及被拒绝的原因。对被拒绝请求背后的原因进行分析,使我们能够分析这些原因与科学不端行为、优先级和不符合生物库使命等问题之间的关系。我们根据 TNGB 在获取决策过程中使用的行动和动机来讨论这些问题。基于此分析,我们建议采用访问评估检查表的交叉实施方法,将改进整个访问流程,确保治理更加透明和顺畅。最后,我们得出结论,TNGB 的章程和获取治理方法可以作为处理该主题国际讨论中出现的问题的重要参考点。

相似文献

1
Governance of Access in Biobanking: The Case of Telethon Network of Genetic Biobanks.生物银行准入治理:以特龙网络遗传生物银行为例。
Biopreserv Biobank. 2021 Dec;19(6):483-492. doi: 10.1089/bio.2021.0057. Epub 2021 Dec 3.
2
The alliance between genetic biobanks and patient organisations: the experience of the telethon network of genetic biobanks.遗传生物样本库与患者组织之间的联盟:泰乐松遗传生物样本库网络的经验
Orphanet J Rare Dis. 2016 Oct 24;11(1):142. doi: 10.1186/s13023-016-0527-7.
3
Telethon Network of Genetic Biobanks: a key service for diagnosis and research on rare diseases.远程通讯遗传生物银行网络:罕见病诊断和研究的关键服务。
Orphanet J Rare Dis. 2013 Aug 30;8:129. doi: 10.1186/1750-1172-8-129.
4
Access Governance for Biobanks: The Case of the BioSHaRE-EU Cohorts.生物样本库的访问管理:以BioSHaRE-EU队列为例。
Biopreserv Biobank. 2016 Jun;14(3):201-6. doi: 10.1089/bio.2015.0124. Epub 2016 May 16.
5
Biobank networking and globalisation: perspectives and practices of Australian biobanks.生物银行网络与全球化:澳大利亚生物银行的视角与实践。
Aust Health Rev. 2021 Mar;45(2):214-222. doi: 10.1071/AH20063.
6
Recommendations for a Dutch Sustainable Biobanking Environment.荷兰可持续生物库环境的建议。
Biopreserv Biobank. 2021 Jun;19(3):228-240. doi: 10.1089/bio.2021.0011. Epub 2021 May 27.
7
"It's all about trust": reflections of researchers on the complexity and controversy surrounding biobanking in South Africa.“一切都关乎信任”:研究人员对南非生物样本库相关复杂性与争议的反思
BMC Med Ethics. 2016 Oct 10;17(1):57. doi: 10.1186/s12910-016-0140-2.
8
[Ethical review of biobanks in The Netherlands: lessons from the String of Pearls Initiative].[荷兰生物样本库的伦理审查:来自“珍珠链计划”的经验教训]
Ned Tijdschr Geneeskd. 2011;155(26):A3557.
9
Exploring how biobanks communicate the possibility of commercial access and its associated benefits and risks in participant documents.探讨生物银行在参与者文件中如何沟通商业访问的可能性及其相关的利益和风险。
BMC Med Ethics. 2022 Sep 21;23(1):95. doi: 10.1186/s12910-022-00829-1.
10
Biobanks and Their Clinical Application and Informatics Challenges.生物样本库及其临床应用与信息学挑战。
Adv Exp Med Biol. 2016;939:241-257. doi: 10.1007/978-981-10-1503-8_10.